최철원 프로필 사진

최철원

Choi, Chul Won

의과대학

의학과

자료 필터

자료유형

발행연도

2006 ~ 2026
2006 2026

키워드

언어

선택된 필터

  • article
  • conference
  • book

전체 315건 중 21번부터 30번까지의 결과를 표시합니다.

2021
Article

Total Platelet Transcriptomics and Its Network Analysis by RNA-Seq and miRNA-Seq and PCA Application in Essential Thrombocythaemia

  • 2021
  • Acta Haematologica
  • KARGER
2020
Article

Efficacy of posaconazole prophylaxis in acute myeloid leukemia and myelodysplastic syndrome patients treated with hypomethylating agents

  • 2020-10
  • Therapeutic Advances in Hematology
  • SAGE PUBLICATIONS LTD
Article

Efficacy and safety of two pegfilgrastim biosimilars: Tripegfilgrastim and pegteograstim

  • 2020-09
  • Cancer Medicine
  • WILEY
Article

The role of platelet function analyzer-200 in predicting perioperative bleeding risk

  • 2020-09
  • The Korean Journal of Internal Medicine
  • KOREAN ASSOC INTERNAL MEDICINE
Article

Immature platelet fraction based diagnostic predictive scoring model for immune thrombocytopenia

  • 2020-07
  • The Korean Journal of Internal Medicine
  • KOREAN ASSOC INTERNAL MEDICINE
Article

Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab

  • 2020-07
  • Annals of Hematology
  • SPRINGER
Article

Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

  • Do, Young Rok ; 
  • Kwak, Jae-Yong ; 
  • Kim, Jeong A. ; 
  • Kim, Hyeoung Joon ; 
  • Chung, Joo Seop ; 
  • ... Choi, Chul Won ; 
  • 외 14명
  • 2020-04
  • British Journal of Haematology
  • WILEY
Article

Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

  • Lee, Ho Sup ; 
  • Kim, Kihyun ; 
  • Kim, Seok Jin ; 
  • Lee, Je-Jung ; 
  • Kim, Inho ; 
  • ... Choi, Chul Won ; 
  • 외 11명
  • 2020-04
  • American Journal of Hematology
  • WILEY
Article

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study

  • 2020-01-08
  • Scientific Reports
  • NATURE PUBLISHING GROUP